Pro12Ala polymorphism of the peroxisome proliferator-activated receptor &gamma;2 in patients with fatty liver diseases

doi:10.3748/wjg.v16.i46.5830

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4583)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

403

HTML

3879

Figures (1-3)

158

Tables (1-6)

143

Sum=4583

Dec 14, 2010 (publication date) through Apr 30, 2024

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 14, 2010; 16(46): 5830-5837
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5830

Full Size Figure Download Figure

Figure 3 GOT and GPT levels in sera of non-alcoholic fatty liver disease (A) or alcoholic fatty liver disease (B) patients carrying the Ala mutated allele or the Pro wild type allele of the peroxisome-proliferator-activated receptor-γ2 gene. NAFLD: Non-alcoholic fatty liver disease; AFLD: Alcoholic fatty liver disease. Dots (●) indicate outliers that are not included between the whiskers.

Citation: Rey JW, Noetel A, Hardt A, Canbay A, Alakus H, Hausen AZ, Dienes HP, Drebber U, Odenthal M. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases. World J Gastroenterol 2010; 16(46): 5830-5837
URL: https://www.wjgnet.com/1007-9327/full/v16/i46/5830.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i46.5830